Updated
Updated · CNN · Aug 7
BSEM Falls $0.09 After Hours After Closing at $4.09
Updated
Updated · CNN · Aug 7

BSEM Falls $0.09 After Hours After Closing at $4.09

1 articles · Updated · CNN · Aug 7

Summary

  • $0.09 of after-hours losses erased BSEM's regular-session gain after the stock closed at $4.09.
  • The shares had risen $0.07, or 1.81%, by the market close before reversing in extended trading.
  • BioStem Technologies carries a $71.69 million market value, placing it in the micro-cap category.
  • The company reported $47.48 million in annual revenue and a $6.58 million net loss, while first-quarter revenue fell to $6.13 million and net loss widened to $8.82 million.

Insights

After an 84 percent revenue plunge, will the risky BioTissue acquisition truly transform this struggling micro-cap into a medical powerhouse?
With cash burning fast, can BioStem's Nasdaq debut today save its ambitious hospital expansion before funds run dry?
Could four newly minted design patents be the secret weapon BioStem needs to dominate the competitive hospital wound care market?